Nasogastric Tube Market Share

North American Market Forecast

North America industry is predicted to dominate majority revenue share of 39% by 2037. The development of various supportive regulatory guidelines by the regulatory bodies in the region that creates several investment opportunities for businesses will drive market growth. For instance, in June 2021, the U.S. FDA introduced the guideline for researching and testing oral drug consumption using the enteral feeding tube. Moreover, the growing cases of heart disease and cancer will surge the demand for nasogastric tubes. Since, these diseases require intensive unit care and surgical procedures, therefore the need for enteral feeding rises.

APAC Market Analysis

Asia Pacific nasogastric tube market is anticipated to hold a notable contribution till 2037. The region has a huge population of older adults. Between 2010 and 2050, the region's population of senior people (those over the age of 60) will triple. One in four people will be above 60 years old, reaching a total population of 1.3 billion by 2050. Due to several reasons, such as poor appetite, and medical conditions, older people face trouble in consuming adequate nutrition orally. Nasogastric tubes help in hydration and nutritional management in them.